Optovue Corporation is an ophthalmic device company dedicated to working with ophthalmologists and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Optovue was founded by the pioneers of Optical Coherence Tomography to develop the next generation ophthalmic diagnosis instrument based on the Fourier-Domain OCT technology. The ultra-high speed high resolution FD-OCT provides physicians with advanced retina diagnostic capabilities that will have significant benefit for patients who have retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases. Optovue’s goal is to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular diseases. We are committed to working with physicians to make the technology work for clinics, and most importantly to benefit patients.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/30/07 | Series B | 10.5M | Acorn Campus Ventures, H&Q Asia Pacific, Harbinger Venture Management, iD SoftCapital, Trevi Health Ventures | Unknown |